TY - JOUR
T1 - An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection
AU - Cabrera, Roniel
AU - Tu, Zhengkun
AU - Xu, Yiling
AU - Firpi, Roberto J.
AU - Rosen, Hugo R.
AU - Liu, Chen
AU - Nelson, David R.
PY - 2004/11
Y1 - 2004/11
N2 - The CD4+CD25+ regulatory T lymphocytes have been implicated in suppressing T cell immune responses. Our aim was to characterize the frequency, phenotype, function, and specificity of CD4+CD25 + T cells in hepatitis C virus (HCV) infection. Peripheral CD4 +CD25+ cells from recovered (n = 15), chronic infected (n = 30), and normal control (n = 15) subjects were analyzed ex vivo for quantitation, phenotype, and effect on HCV-specific Interferon gamma production and proliferation, CD4+CD25+ specificity was determined by intracellular cytokine staining for interleukin 10 (IL-10). A higher proportion of CD4+CD25+ were found in chronic infection (mean, 3.02%) when compared with recovered (1.64%, P = .001) and normal controls (2.27%, P = .02). CD4+CD25+ cells display CD45RO high, CD45RAlow, CD28high, CD62L high, and CD95high phenotype. HCV-specific interferon gamma activity was enhanced in peripheral blood mononuclear cells depleted of CD4+CD25+ and suppressed in peripheral blood mononuclear cells enriched with CD4+CD25+. Depletion of CD4 +CD25+ cells also enhanced HCV-specific CD4+ and CD8+ T cell proliferation. Cytokine analysis suggested CD4 +CD25+ cells secrete transforming growth factor beta (TGF-β1) and IL-10. The inhibitory role for TGF- β1 was confirmed by anti-TGF-β1. Transwell studies showed CD4+CD25+ mediated suppression to be dose dependent and requiring cell contact. CD4+CD25+ cells showed HCV-specificity through IL-10 production, with a frequency ranging from 1.9% to 5.3%. A positive correlation was detected between CD4 +CD25+ T cell frequency and HCV RNA titer, whereas an inverse relation was found with liver inflammatory activity. In conclusion, CD4+CD25+ T lymphocytes constitute a highly differentiated population and appear to play a role in viral persistence by suppressing HCV-specific T cell responses in a cell-cell contact manner.
AB - The CD4+CD25+ regulatory T lymphocytes have been implicated in suppressing T cell immune responses. Our aim was to characterize the frequency, phenotype, function, and specificity of CD4+CD25 + T cells in hepatitis C virus (HCV) infection. Peripheral CD4 +CD25+ cells from recovered (n = 15), chronic infected (n = 30), and normal control (n = 15) subjects were analyzed ex vivo for quantitation, phenotype, and effect on HCV-specific Interferon gamma production and proliferation, CD4+CD25+ specificity was determined by intracellular cytokine staining for interleukin 10 (IL-10). A higher proportion of CD4+CD25+ were found in chronic infection (mean, 3.02%) when compared with recovered (1.64%, P = .001) and normal controls (2.27%, P = .02). CD4+CD25+ cells display CD45RO high, CD45RAlow, CD28high, CD62L high, and CD95high phenotype. HCV-specific interferon gamma activity was enhanced in peripheral blood mononuclear cells depleted of CD4+CD25+ and suppressed in peripheral blood mononuclear cells enriched with CD4+CD25+. Depletion of CD4 +CD25+ cells also enhanced HCV-specific CD4+ and CD8+ T cell proliferation. Cytokine analysis suggested CD4 +CD25+ cells secrete transforming growth factor beta (TGF-β1) and IL-10. The inhibitory role for TGF- β1 was confirmed by anti-TGF-β1. Transwell studies showed CD4+CD25+ mediated suppression to be dose dependent and requiring cell contact. CD4+CD25+ cells showed HCV-specificity through IL-10 production, with a frequency ranging from 1.9% to 5.3%. A positive correlation was detected between CD4 +CD25+ T cell frequency and HCV RNA titer, whereas an inverse relation was found with liver inflammatory activity. In conclusion, CD4+CD25+ T lymphocytes constitute a highly differentiated population and appear to play a role in viral persistence by suppressing HCV-specific T cell responses in a cell-cell contact manner.
UR - http://www.scopus.com/inward/record.url?scp=7044247947&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=7044247947&partnerID=8YFLogxK
U2 - 10.1002/hep.20454
DO - 10.1002/hep.20454
M3 - Article
C2 - 15486925
AN - SCOPUS:7044247947
SN - 0270-9139
VL - 40
SP - 1062
EP - 1071
JO - Hepatology
JF - Hepatology
IS - 5
ER -